Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review
Mycophenolate mofetil (MMF) is an antimetabolite with a potent inhibitory effect on proliferation of T and B lymphocytes used since the early 1990s for the prevention of acute allograft rejection after organ transplant. MMF is also widely used for the treatment of a variety of rheumatic diseases (RD...
Main Authors: | Giulia Cassone, Marco Sebastiani, Caterina Vacchi, Gian Luca Erre, Carlo Salvarani, Andreina Manfredi |
---|---|
Format: | Article |
Language: | English |
Published: |
BioExcel Publishing Ltd
2021-01-01
|
Series: | Drugs in Context |
Subjects: | |
Online Access: | https://www.drugsincontext.com/efficacy-and-safety-of-mycophenolate-mofetil-in-the-treatment-of-rheumatic-disease-related-interstitial-lung-disease:-a-narrative-review |
Similar Items
-
Interstitial Lung Disease with Autoimmune Features Successfully Treated with Mycophenolate Mofetil: Case Report
by: Sabrina Khuder, et al.
Published: (2023-12-01) -
Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease
by: Caterina Vacchi, et al.
Published: (2021-01-01) -
STUDY OF THE EFFICIENCY AND SAFETY OF MYCOPHENOLATE MOFETIL THERAPY IN PATIENTSWITH SYSTEMIC SCLERODERMA
by: O A Koneva, et al.
Published: (2011-08-01) -
Mycophenolate Mofetil Improves Exercise Tolerance in Systemic Sclerosis Patients with Interstitial Lung Disease: A Pilot Study
by: Valentina Vaiarello, et al.
Published: (2020-08-01) -
Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies
by: C Bandelier
Published: (2009-01-01)